1-3 of 3
Kai Witte
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Transfer of Ex Vivo Expanded NK and γδT Cells from Untouched Posttransplant PBMCs to Clear Minimal Residual Disease in Acute Myeloid Leukemia

Patrick Schlegel, MD, Chihab Klose, PhD, Christina Kyzirakos, PhD, Ursula J.E. Seidel, Kai Witte, Annika Horrer, Marie Matela, Matthias Pfeiffer, MD, Rupert Handgretinger, Peter Lang, MD
Journal: Blood
Blood (2014) 124 (21): 5294.
https://doi.org/10.1182/blood.V124.21.5294.5294
Published: 2014
Journal Articles

Use of a Fc-Optimized CD19 Antibody for Treatment of MRD in Pediatric Patients with B-Lineage Acute Lymphoblastic Leukemia

Peter Lang, MD, Heiko-Manuel Teltschik, MD, Patrick Schlegel, MD, Ursula Seidel, Ludger Grosse-Hovest, PhD, Steffen Aulwurm, PhD, Martin Hofmann, Rouwen Teltschik, Kai Witte, MD, Hans-Georg Rammensee, Prof., Gundram Jung, MD, Rupert Handgretinger, MD
Journal: Blood
Blood (2012) 120 (21): 581.
https://doi.org/10.1182/blood.V120.21.581.581
Published: 2012
Journal Articles

High Progenitor Cell Frequency at Diagnosis Predicts High Minimal residual Disease Level in Childhood ALL.

Martin Ebinger, Kai Witte, Peter J. Lang, MD, Rupert Handgretinger
Journal: Blood
Blood (2009) 114 (22): 4705.
https://doi.org/10.1182/blood.V114.22.4705.4705
Published: 2009